Non-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation and Associated Intracranial Hemorrhage: A Focused Review

被引：7

作者：

Arbit, Boris ^{[1
]}

Hsu, Jonathan C. ^{[1
]}

机构：

[1] Univ Calif San Diego, Dept Med, Div Cardiol, Cardiac Electrophysiol Sect, La Jolla, CA 92093 USA

来源：

CLINICAL CARDIOLOGY | 2015年 / 38卷 / 11期

关键词：

PROTHROMBIN COMPLEX CONCENTRATE; DIRECT THROMBIN INHIBITOR; ACUTE ISCHEMIC-STROKE; PARTIAL THROMBOPLASTIN TIME; RECOMBINANT FACTOR VIIA; FACTOR XA INHIBITOR; DABIGATRAN ETEXILATE; IN-VITRO; LABORATORY MEASUREMENT; COAGULATION ASSAYS;

D O I：

10.1002/clc.22434

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Atrial fibrillation (AF) is the most common cardiac arrhythmia and predisposes patients to an increased risk of embolic stroke. After nearly 60 years, warfarin is no longer the only effective therapeutic option for patients with AF. Large randomized trials have consistently shown that non- vitamin K oral anticoagulants (NOACs) including dabigatran, rivaroxaban, apixaban, and edoxaban significantly reduce from the risk of intracranial hemorrhage (ICH) compared with warfarin. We provide a focused review regarding the NOACs and ICH in AF patients by summarizing findings of these large clinical trials, mechanisms of lower ICH, reversal strategies with specific agents, and monitoring strategies.

引用

页码：684 / 691

页数：8

共 76 条

[21] Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate A Randomized, Placebo-Controlled, Crossover Study in Healthy Subjects [J].

Eerenberg, Elise S. ;

Kamphuisen, Pieter W. ;

Sijpkens, Meertien K. ;

Meijers, Joost C. ;

Buller, Harry R. ;

Levi, Marcel .

CIRCULATION, 2011, 124 (14) :1573-1579

[22] A New Risk Scheme to Predict Warfarin-Associated Hemorrhage The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study [J].

Fang, Margaret C. ;

Go, Alan S. ;

Chang, Yuchiao ;

Borowsky, Leila H. ;

Pomernacki, Niela K. ;

Udaltsova, Natalia ;

Singer, Daniel E. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (04) :395-401

[23] The Challenge of Designing a Treatment Trial for Warfarin-Associated Intracerebral Hemorrhage [J].

Flaherty, Matthew L. ;

Adeoye, Opeolu ;

Sekar, Padmini ;

Haverbusch, Mary ;

Moomaw, Charles J. ;

Tao, Haiyang ;

Broderick, Joseph P. ;

Woo, Daniel .

STROKE, 2009, 40 (05) :1738-1742

[24]

FURIE B, 1992, NEW ENGL J MED, V326, P800

[25] Laboratory assessment of the anticoagulant effects of the next generation of oral anticoagulants [J].

Garcia, D. ;

Barrett, Y. C. ;

Ramacciotti, E. ;

Weitz, J. I. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (02) :245-252

[26] Edoxaban versus Warfarin in Patients with Atrial Fibrillation [J].

Giugliano, Robert P. ;

Ruff, Christian T. ;

Braunwald, Eugene ;

Murphy, Sabina A. ;

Wiviott, Stephen D. ;

Halperin, Jonathan L. ;

Waldo, Albert L. ;

Ezekowitz, Michael D. ;

Weitz, Jeffrey I. ;

Spinar, Jindrich ;

Ruzyllo, Witold ;

Ruda, Mikhail ;

Koretsune, Yukihiro ;

Betcher, Joshua ;

Shi, Minggao ;

Grip, Laura T. ;

Patel, Shirali P. ;

Patel, Indravadan ;

Hanyok, James J. ;

Mercuri, Michele ;

Vogelmann, O. ;

Gonzalez, C. ;

Ahuad Guerrero, R. ;

Rodriguez, M. ;

Albisu, J. ;

Rosales, E. ;

Allall, O. ;

Reguero, M. ;

Alvarez, C. ;

Garcia, M. ;

Ameriso, S. ;

Ameriso, P. ;

Amuchastegui, M. ;

Caceres, M. ;

Beloscar, J. ;

Petrucci, J. ;

Berli, M. ;

Budassi, N. ;

Valle, M. ;

Bustamante Labarta, G. ;

Saravia, M. ;

Caccavo, A. ;

Fracaro, V. ;

Cartasegna, L. ;

Novas, V. ;

Caruso, O. ;

Saa Zarandon, R. ;

Colombo, H. ;

Morandini, M. ;

Cuello, J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (22) :2093-2104

[27] In Vitro and In Vivo P-Glycoprotein Transport Characteristics of Rivaroxaban [J].

Gnoth, Mark Jean ;

Buetehorn, Ulf ;

Muenster, Uwe ;

Schwarz, Thomas ;

Sandmann, Steffen .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 338 (01) :372-380

[28] Assessment of apixaban plasma levels by laboratory tests: suitability of three anti-Xa assays [J].

Gouin-Thibault, Isabelle ;

Flaujac, Claire ;

Delavenne, Xavier ;

Quenet, Sara ;

Horellou, Marie-Helene ;

Laporte, Silvy ;

Siguret, Virginie ;

Lecompte, Thomas .

THROMBOSIS AND HAEMOSTASIS, 2014, 111 (02) :240-248

[29] Apixaban versus Warfarin in Patients with Atrial Fibrillation [J].

Granger, Christopher B. ;

Alexander, John H. ;

McMurray, John J. V. ;

Lopes, Renato D. ;

Hylek, Elaine M. ;

Hanna, Michael ;

Al-Khalidi, Hussein R. ;

Ansell, Jack ;

Atar, Dan ;

Avezum, Alvaro ;

Cecilia Bahit, M. ;

Diaz, Rafael ;

Easton, J. Donald ;

Ezekowitz, Justin A. ;

Flaker, Greg ;

Garcia, David ;

Geraldes, Margarida ;

Gersh, Bernard J. ;

Golitsyn, Sergey ;

Goto, Shinya ;

Hermosillo, Antonio G. ;

Hohnloser, Stefan H. ;

Horowitz, John ;

Mohan, Puneet ;

Jansky, Petr ;

Lewis, Basil S. ;

Luis Lopez-Sendon, Jose ;

Pais, Prem ;

Parkhomenko, Alexander ;

Verheugt, Freek W. A. ;

Zhu, Jun ;

Wallentin, Lars .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (11) :981-992

[30] The effect of dabigatran on the activated partial thromboplastin time and thrombin time as determined by the Hemoclot thrombin inhibitor assay in patient plasma samples [J].

Hapgood, Greg ;

Butler, Jenny ;

Malan, Erica ;

Chunilal, Sanjeev ;

Tran, Huyen .

THROMBOSIS AND HAEMOSTASIS, 2013, 110 (02) :308-315

← 1 2 3 4 5 6 7 8 →